Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance

被引:0
作者
Michele Dal-Bo
Francesco Bertoni
Francesco Forconi
Antonella Zucchetto
Riccardo Bomben
Roberto Marasca
Silvia Deaglio
Luca Laurenti
Dimitar G Efremov
Gianluca Gaidano
Giovanni Del Poeta
Valter Gattei
机构
[1] Centro di Riferimento Oncologico,Clinical and Experimental Onco
[2] I.R.C.C.S.,Hematology Unit
[3] Oncology Institute of Southern Switzerland,Laboratory of Experimental Oncology and Lymphoma Unit
[4] University of Siena,Division of Hematology and Transplant, Department of Clinical Medicine and Immunological Sciences
[5] Department of Oncology and Hematology-University of Modena and Reggio Emilia,Division of Hematology
[6] University of Turin,Laboratory of Immunogenetics, Department of Genetics, Biology and Biochemistry and CeRMS
[7] Catholic University "Sacro Cuore",Hematology Institute
[8] ICGEB Outstation-Monterotondo,Molecular Hematology
[9] Department of Clinical and Experimental Medicine & BRMA – Amedeo Avogadro University of Eastern Piedmont,Division of Hematology
[10] S.Eugenio Hospital and University of Tor Vergata,Chair of Hematology
来源
Journal of Translational Medicine | / 7卷
关键词
Chronic Lymphocytic Leukemia; Telomere Length; TP53 Mutation; Chronic Lymphocytic Leukemia Patient; Chronic Lymphocytic Leukemia Cell;
D O I
暂无
中图分类号
学科分类号
摘要
B-cell chronic lymphocytic leukemia (CLL), the most frequent leukemia in the Western world, is characterized by extremely variable clinical courses with survivals ranging from 1 to more than 15 years. The pathogenetic factors playing a key role in defining the biological features of CLL cells, hence eventually influencing the clinical aggressiveness of the disease, are here divided into "intrinsic factors", mainly genomic alterations of CLL cells, and "extrinsic factors", responsible for direct microenvironmental interactions of CLL cells; the latter group includes interactions of CLL cells occurring via the surface B cell receptor (BCR) and dependent to specific molecular features of the BCR itself and/or to the presence of the BCR-associated molecule ZAP-70, or via other non-BCR-dependent interactions, e.g. specific receptor/ligand interactions, such as CD38/CD31 or CD49d/VCAM-1. A putative final model, discussing the pathogenesis and the clinicobiological features of CLL in relationship of these factors, is also provided.
引用
收藏
相关论文
共 1440 条
[1]  
Moreno C(2008)New prognostic markers in chronic lymphocytic leukemia Blood Rev 22 211-219
[2]  
Montserrat E(1995)p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias Blood 85 1580-1589
[3]  
Dohner H(1999)Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1840-1847
[4]  
Fischer K(2000)Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med 343 1910-1916
[5]  
Bentz M(2004)ZAP-70 expression and prognosis in chronic lymphocytic leukaemia Lancet 363 105-111
[6]  
Hansen K(2004)Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery Br J Haematol 126 29-42
[7]  
Benner A(2004)ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med 351 893-901
[8]  
Cabot G(2008)Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia Blood 111 865-873
[9]  
Diehl D(2006)Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia Blood 107 742-751
[10]  
Schlenk R(2007)Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping Leukemia 21 2442-2451